CL2007002425A1 - Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica. - Google Patents

Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.

Info

Publication number
CL2007002425A1
CL2007002425A1 CL200702425A CL2007002425A CL2007002425A1 CL 2007002425 A1 CL2007002425 A1 CL 2007002425A1 CL 200702425 A CL200702425 A CL 200702425A CL 2007002425 A CL2007002425 A CL 2007002425A CL 2007002425 A1 CL2007002425 A1 CL 2007002425A1
Authority
CL
Chile
Prior art keywords
sodium salt
ibuprofen
procedure
size
medium particle
Prior art date
Application number
CL200702425A
Other languages
English (en)
Inventor
V Phan Hao
Original Assignee
Albermarle Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38658432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007002425(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Albermarle Corp filed Critical Albermarle Corp
Publication of CL2007002425A1 publication Critical patent/CL2007002425A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C07C51/44—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation by distillation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL200702425A 2006-08-22 2007-08-21 Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica. CL2007002425A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83933806P 2006-08-22 2006-08-22

Publications (1)

Publication Number Publication Date
CL2007002425A1 true CL2007002425A1 (es) 2008-06-27

Family

ID=38658432

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702425A CL2007002425A1 (es) 2006-08-22 2007-08-21 Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.

Country Status (9)

Country Link
US (1) US20090305041A1 (es)
EP (1) EP2054367B1 (es)
AR (1) AR062485A1 (es)
BR (1) BRPI0716042A2 (es)
CA (1) CA2659865A1 (es)
CL (1) CL2007002425A1 (es)
ES (1) ES2625931T3 (es)
MX (1) MX2009001524A (es)
WO (1) WO2008024820A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002425A1 (es) 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
GB0807919D0 (es) 2008-05-01 2008-06-04 Moorlodge Biotech Ventures Ltd
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
CN102336650B (zh) * 2011-07-19 2013-12-11 青岛科技大学 脱除布洛芬钠盐中有机杂质的汽提工艺与装置
CN103880650B (zh) * 2012-12-19 2016-03-02 山东新华制药股份有限公司 一种布洛芬钠盐精制装置及工艺
CN111807949B (zh) * 2020-07-23 2022-02-11 青岛科技大学 一种从布洛芬钠盐母液中回收布洛芬钠盐的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US4189596A (en) * 1976-05-24 1980-02-19 The Upjohn Company Preparing 2-arylalkanoic acid derivatives
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4282252A (en) * 1980-05-15 1981-08-04 Thomas Jefferson University Method of increasing coronary blood flow with ibuprofen
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
US4447451A (en) * 1981-07-20 1984-05-08 The Upjohn Manufacturing Company M Treatment of adult respiratory distress syndrome
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4623736A (en) * 1982-07-09 1986-11-18 The Upjohn Company Arylalkanoic acid process improvement
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4439450A (en) * 1983-06-30 1984-03-27 The Upjohn Manufacturing Company M Treatment of the blood-brain barrier with ibuprofen
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4569937A (en) * 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
UA34430C2 (uk) 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію
US5260482A (en) 1992-10-14 1993-11-09 Ethyl Corporation Enantiomeric resolution
US5256816A (en) 1992-10-14 1993-10-26 Ethyl Corporation Enantiomeric resolution
GB9224021D0 (en) 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
DE19624607A1 (de) * 1996-06-20 1998-01-02 Basf Ag Verfahren zur Herstellung von Salzen von Säuregruppen tragenden pharmazeutischen Wirkstoffen
CH693586A8 (de) 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CL2007002425A1 (es) 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.

Also Published As

Publication number Publication date
EP2054367A2 (en) 2009-05-06
EP2054367B1 (en) 2017-03-22
WO2008024820A2 (en) 2008-02-28
MX2009001524A (es) 2009-02-18
US20090305041A1 (en) 2009-12-10
ES2625931T3 (es) 2017-07-21
WO2008024820A3 (en) 2008-05-02
CA2659865A1 (en) 2008-02-28
AR062485A1 (es) 2008-11-12
BRPI0716042A2 (pt) 2013-09-17

Similar Documents

Publication Publication Date Title
CL2007002425A1 (es) Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
BRPI0716116A2 (pt) partÍculas catalÍticas tipo nécleo/casca e mÉtodos para sua preparaÇço
IL188732A (en) Use of ibuprofen and famotidine in the preparation of medicaments
DK2069439T3 (da) Nanokompositpartikel og fremgangsmåde til fremstilling deraf
PT2029173T (pt) Anticorpos específicos fc rib e seus métodos de uso
EP2099364B8 (en) Detection of the detachment of immobilized contrast agent in medical imaging applications
EP1977383A4 (en) SYSTEMS AND METHODS FOR SIMPLIFYING THE CONCLUSION OF REPURCHASE AGREEMENTS
EP2170283A4 (en) FORMATION OF A STABLE SUBMICRON PEPTIDE OR PROTEIN PARTICLES THROUGH THIN FILM FREEZERS
PT2059535E (pt) Anticorpos específicos do prlr e suas utulizações
DK2091663T3 (da) Ultralydsvæskeforstøver
IL194792A (en) Arrayed imaging systems and associated method
EP2038320A4 (en) PARTICLES WITH MULTI-BLOCKPOLYMERS
EP2044224A4 (en) CHIMERIC VIRUS TYPE PARTICLES
WO2008057159A3 (en) Apparatus and method for tracking a molecule or particle in three dimensions
EP1968451A4 (en) SYSTEMS AND METHOD FOR IMPROVING THE RESOLUTION OF ULTRASONIC IMAGES WITH MULTIPLE TRANSDUCERS
DE602008006335D1 (de) Impedanzanpassungsverfahren und diese durchführende Systeme
AU2005337776A1 (en) Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent
BRPI0818351A2 (pt) Métodos para formação de partículas de sal metálico estabilizadas
IL188353A0 (en) Interleukin-1 and tumor necrosis factor-a modulators: syntheses of such modulators and methods of using such modulators
BRPI0813888A2 (pt) Interfaces de sistema sob encomenda e características
DE602007010428D1 (de) Teilcheneingeschlossener nanoschalter
CL2007002291A1 (es) Composicion para tratamiento de bebidas que comprende particulas de xerogel con volumen de poros entre 0,2-2 ml/g y tamano medio de particula 5-40 micrones, donde la composicion comprende hasta 20% de finos; metodo para elaborar composicion; y metodo
EP2030522A4 (en) DEVICE FOR FEEDING LOADED PARTICLES
ITMI20050353A1 (it) Sistema di interoperabilita' di applicazioni eseguibili e creazione di interfaccia
EP1922692A4 (en) SYSTEMS AND METHOD FOR PROVIDING DATA PROCESSING SERVICES FOR MULTIPLE ENTITIES